Scholarlink

<p>mRNA vaccines have ushered in a&#xa0;new era of medicine, characterized by their short development times, ease of scalability, and high efficacy and safety, as demonstrated during the COVID-19 pandemic. Cancer mRNA vaccines are considered a&#xa0;promising breakthrough in personalized cancer treatment. This technology utilizes tailored mRNA sequences to activate the immune system to combat tumor cells, often in combination with established therapies such as checkpoint inhibitors. Currently, several mRNA-based cancer vaccines are undergoing advanced clinical trials, with initial regulatory approvals anticipated in the coming years.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

mRNA-Impfungen gegen Krebs

  • 期刊论文

  • 发表日期：

    2025年6月13日

查看全文
  • Joschka Heil,
  • Sara Sander,
  • Uwe M. Martens

摘要

mRNA vaccines have ushered in a new era of medicine, characterized by their short development times, ease of scalability, and high efficacy and safety, as demonstrated during the COVID-19 pandemic. Cancer mRNA vaccines are considered a promising breakthrough in personalized cancer treatment. This technology utilizes tailored mRNA sequences to activate the immune system to combat tumor cells, often in combination with established therapies such as checkpoint inhibitors. Currently, several mRNA-based cancer vaccines are undergoing advanced clinical trials, with initial regulatory approvals anticipated in the coming years.